Alice Mims, MD
Beat AML · Ohio State University Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alice Mims, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:38 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT03013998 · Study of Biomarker-Based Treatment of Acute Myeloid LeukemiaBeat AML, LLC · recruiting · Previously Untreated Relapsed Refractory Acute Myeloid Leukemia · principal investigator
- Ph1NCT02299518 · Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaAlice Mims · completed · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.